open access
Effectiveness of nivolumab in an elderly patient with metastatic BRAF-negative melanoma originating from the anal region
open access
Abstract
Abstract
Keywords
melanoma, senior age, anti-PD-1, nivolumab


Title
Effectiveness of nivolumab in an elderly patient with metastatic BRAF-negative melanoma originating from the anal region
Journal
Issue
Article type
Case report
Pages
308-310
Published online
2018-01-04
Page views
308
Article views/downloads
440
DOI
10.5603/OCP.2017.0032
Bibliographic record
Oncol Clin Pract 2017;13(6):308-310.
Keywords
melanoma
senior age
anti-PD-1
nivolumab
Authors
Jacek Calik


- Brudnik U, Wojas-Pelc A, Branicki W. Genetyczne uwarunkowania czerniaka. Post Dermatol Alergol. 2006; 1: 21–25.
- Callahan MK, Wolchok JD. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol. 2013; 94(1): 41–53.
- Elias R, Morales J, Rehman Y, et al. Immune Checkpoint Inhibitors in Older Adults. Curr Oncol Rep. 2016; 18(8): 47.
- Krzakowski M, Warzocha K. Zalecenia postępowania diagnostyczno - terapeutycznego w nowotworach złośliwych. Via Medica, Gdańsk 2013: 422.
- Mackiewicz J, Kwinta Ł. Nowe terapie celowane stosowane u chorych na czerniaka uogólnionego. Współczesna Onkologia. 2010; 14(1): 15–22.
- Ruka W, Nowecki Z, Rutkowski P. Czerniaki skóry u dorosłych monografia. Medipage. 2005: Warszawa.
- Rutkowski P. Nowotwory złośliwe skóry. Via Medica 2014.
- Scolyer RA, Long GV, Thompson JF. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care. Mol Oncol. 2011; 5(2): 124–136.